[Localized prostate cancer: Radiotherapeutic concepts]
- PMID: 26895435
- DOI: 10.1007/s00120-016-0042-4
[Localized prostate cancer: Radiotherapeutic concepts]
Abstract
Background: Radiation therapy is an established cornerstone in the treatment of prostate cancer. Significant advances in the techniques and therapeutic concepts have been made in recent decades.
Objectives: The objective of this article is to provide an overview of current standards of care and recent technical and conceptional developments.
Conclusions: Three-dimensional conformal radiotherapy has long been the standard of care for percutaneous radiotherapy. The development of intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT) have increased the precision of treatment, thus, reducing side effects and allowing dose escalation. LDR (low dose rate) and HDR (high dose rate) brachytherapy alone or in combination are a treatment option in localized prostate cancer with a distinct side effect profile. The roles of proton therapy and stereotactic radiotherapy should be further investigated in prospective trials.
Keywords: Brachytherapy; Prostate cancer; Radiotherapy, external-beam; Radiotherapy, image-guided; Radiotherapy, intensity-modulated.
Similar articles
-
[Curative radiotherapy of localized prostate cancer. Treatment methods and results].Urologe A. 2003 Sep;42(9):1212-20. doi: 10.1007/s00120-003-0428-y. Urologe A. 2003. PMID: 14504754 Review. German.
-
Intensity-modulated radiotherapy causes fewer side effects than three-dimensional conformal radiotherapy when used in combination with brachytherapy for the treatment of prostate cancer.Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):630-5. doi: 10.1016/j.ijrobp.2011.06.2013. Epub 2011 Nov 16. Int J Radiat Oncol Biol Phys. 2012. PMID: 22099032
-
Phase I/II trial of single-fraction high-dose-rate brachytherapy-boosted hypofractionated intensity-modulated radiation therapy for localized adenocarcinoma of the prostate.Brachytherapy. 2012 Jul-Aug;11(4):292-8. doi: 10.1016/j.brachy.2011.07.006. Epub 2012 Mar 30. Brachytherapy. 2012. PMID: 22464911 Clinical Trial.
-
Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.Radiother Oncol. 2012 Aug;104(2):181-6. doi: 10.1016/j.radonc.2012.07.003. Epub 2012 Jul 30. Radiother Oncol. 2012. PMID: 22853851 Clinical Trial.
-
Radiotherapeutic techniques for prostate cancer, dose escalation and brachytherapy.Clin Oncol (R Coll Radiol). 2005 Oct;17(7):560-71. doi: 10.1016/j.clon.2005.07.006. Clin Oncol (R Coll Radiol). 2005. PMID: 16238144 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical